75F40121C00096
Definitive Contract
Overview
Government Description
IMPROVING CLINICAL TRIAL DIVERSITY AND PARTICIPATION AMONG PEOPLE LIVING WITH CHRONIC HEPATITIS B PERCEPTIONS AND CHALLENGES
Awardee
Awarding / Funding Agency
Place of Performance
Doylestown, PA 18902 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
<1
Related Opportunity
None
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/16/22 to 09/16/23.
Hepatitis B Foundation was awarded
Definitive Contract 75F40121C00096 (75F401-21-C-00096)
worth up to $63,081
by the FDA Office of Acquisition and Grant Services
in September 2021.
The contract
has a duration of 2 years and
was awarded
full & open
with
NAICS 813212 and
PSC B529
via direct negotiation acquisition procedures with 1 bid received.
Status
(Complete)
Last Modified 10/26/22
Period of Performance
9/15/21
Start Date
9/16/23
Current End Date
9/16/23
Potential End Date
Obligations
$63.1K
Total Obligated
$63.1K
Current Award
$63.1K
Potential Award
Award Hierarchy
Definitive Contract
75F40121C00096
Subcontracts
Activity Timeline
Transaction History
Modifications to 75F40121C00096
People
Suggested agency contacts for 75F40121C00096
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
KFS3TBNKPGM7
Awardee CAGE
48Y79
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsrpalaniandy
Last Modified By
hhsrpalaniandy
Approved By
hhsrpalaniandy
Legislative
Legislative Mandates
None Applicable
Performance District
PA-01
Senators
Robert Casey
John Fetterman
John Fetterman
Representative
Brian Fitzpatrick
Modified: 10/26/22